AGIOS PHARMACEUTICALS, INC.: net_income
| Value | {"amount": -231801000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | superseded |
| Entity | AGIOS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:11:29.585785+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/200bac15-6014-4984-a8fd-59f538576330
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001439222-23-000039Retrieved: 2026-08-19T14:11:29.585785+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001439222/net-income/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/200bac15-6014-4984-a8fd-59f538576330
History
- no predecessors — first report